Targeting Zero Infections: Multi-Drug Resistant Organisms (MDROs) and Antimicrobial Stewardship in the Dialysis Facility

dialysis CDC logo - Copy_1.jpg

Registration is now open for the second webinar in the Nephrologists Transforming Dialysis Safety (NTDS) webinar series!  Join your colleagues on September 27 from 12:00 – 1:00 PM EDT. 

Multidrug-resistant organisms (MDRO) are an important cause of healthcare associated infection and these infections are associated with significant morbidity and mortality.  Patients undergoing dialysis are at higher risk of infection due to MDRO because of the communal dialysis setting and substantial antibiotic exposure.new ntds september 2017 text box.PNG

This second educational session will review MDRO prevalence and spread in the outpatient dialysis facility and discuss how to improve antimicrobial prescribing patterns with antimicrobial stewardship programs.

Webinar highlights include:

  • Dr. Ikizler will present a case describing a MDRO with a potentially disastrous outcome.
  • Dr. D’Agata will utilize the case to illustrate the increasing challenge with MDROs in the dialysis population and highlight the critical need for an antibiotic stewardship program in your dialysis facility.
  • References to resources the nephrology team may use for environmental cleaning, MDRO management, and antibiotic stewardship will be provided. 


BACKGROUND

For several years, the CDC worked with dialysis companies to promote evidence-based best practices and useful tools to prevent bloodstream infections (BSI) and hepatitis C virus (HCV) infections.  The NTDS project aims to more directly involve nephrologists as team leaders and as professional role models to reduce the burden of BSI and other healthcare-related infections in dialysis patients.

Building upon the foundational principles of the CDC’s Making Dialysis Safer for Patients Coalition, the NTDS project is aimed at transforming dialysis care to make infection prevention part of the fabric of everyday care for dialysis patients.

Key practices in reducing infections include environmental cleaning, MDRO management, and antibiotic stewardship.  Antibiotic stewardship has been deployed in hospitals, but is not generally part of dialysis facility operations.  These efforts improve outcomes in several ways. When antibiotics are administered only when there are clear indications for their use, fewer patients harbor antibiotic resistant organisms or develop multiple antibiotic-resistant infections.  Tailoring antibiotic administration to the agent appropriate for the organism and type of infection reduces the pressure on organisms to develop antibiotic resistance. In addition, it is now becoming clearer that the health-promoting gut microbiome can be permanently altered by multiple courses of antibiotics.  Antibiotic stewardship reduces unnecessary exposure to antibiotics, and better preserves the normal gut microbiome.  Dialysis patients are often prescribed courses of antibiotics, including wide spectrum agents.  Antibiotic stewardship programs in dialysis facilities have the potential to substantially reduce unnecessary exposure of patients to these antibiotics.

NTDS EDUCATIONAL SERIES

This webinar is the second offering in the NTDS educational series for dialysis caregivers.  The first webinar, attended by over 500 nephrologists and other professionals, was entitled “Targeting Zero Infections: Where Do We Begin?”.  This case-based conference stressed several key educational points, including the virulence of hepatitis C, the role of the nephrologist as a leader, and direction to the online resource library.

NTDS’ educational series will continue during ASN’s Kidney Week 2017:

  • November 1, 2017:   Early Program seminar: “The Dialysis Infection Crisis in the United States: A Call to Action” (Register here)
  • November 2, 2017:   Focus Group session
  • November 3, 2017:   Annual session: “Infection Prevention: Are You Prepared for the Next Ebola?”

For the coming year, NTDS will continue to expand its education and physician engagement activities, present a series of articles in Clinical Journal of the American Society of Nephrology, complete and share a curriculum for trainees and medical directors to stop preventable infections, complete and share a guideline for anticipating and preparing for emerging threats, and encourage collaboration between dialysis professionals and state/federal HAI programs.  In addition, NTDS will work with dialysis facilities to develop and refine programs to transform the dialysis culture to a culture of safety and individual accountability.  By engaging nephrologists, dialysis facility owners, and other stakeholders in these many transforming activities, NTDS believes we can get to our target of zero preventable infections.

WEBINAR Speakers

kliger.jpg

ALAN S. KLIGER, MD


NTDS CHAIR

Yale New Haven Health System

ikizler.jpg

T. ALP IKIZLER, MD, FASN


Current & Emerging Threats Co-Chair

Professor of Medicine
Director of Clinical Research in Nephrology

Director, Master of Science in Clinical Investigation Program

Vanderbilt University School of Medicine

dagata.jpg

ERIKA D’AGATA, MD, MPH


Current & Emerging Threats Member
Associate Professor of Medicine

Brown University

Category:
Subcategory:
Body:

dialysis CDC logo - Copy_1.jpg

Registration is now open for the second webinar in the Nephrologists Transforming Dialysis Safety (NTDS) webinar series!  Join your colleagues on September 27 from 12:00 – 1:00 PM EDT. 

Multidrug-resistant organisms (MDRO) are an important cause of healthcare associated infection and these infections are associated with significant morbidity and mortality.  Patients undergoing dialysis are at higher risk of infection due to MDRO because of the communal dialysis setting and substantial antibiotic exposure.new ntds september 2017 text box.PNG

This second educational session will review MDRO prevalence and spread in the outpatient dialysis facility and discuss how to improve antimicrobial prescribing patterns with antimicrobial stewardship programs.

Webinar highlights include:

  • Dr. Ikizler will present a case describing a MDRO with a potentially disastrous outcome.
  • Dr. D’Agata will utilize the case to illustrate the increasing challenge with MDROs in the dialysis population and highlight the critical need for an antibiotic stewardship program in your dialysis facility.
  • References to resources the nephrology team may use for environmental cleaning, MDRO management, and antibiotic stewardship will be provided. 


BACKGROUND

For several years, the CDC worked with dialysis companies to promote evidence-based best practices and useful tools to prevent bloodstream infections (BSI) and hepatitis C virus (HCV) infections.  The NTDS project aims to more directly involve nephrologists as team leaders and as professional role models to reduce the burden of BSI and other healthcare-related infections in dialysis patients.

Building upon the foundational principles of the CDC’s Making Dialysis Safer for Patients Coalition, the NTDS project is aimed at transforming dialysis care to make infection prevention part of the fabric of everyday care for dialysis patients.

Key practices in reducing infections include environmental cleaning, MDRO management, and antibiotic stewardship.  Antibiotic stewardship has been deployed in hospitals, but is not generally part of dialysis facility operations.  These efforts improve outcomes in several ways. When antibiotics are administered only when there are clear indications for their use, fewer patients harbor antibiotic resistant organisms or develop multiple antibiotic-resistant infections.  Tailoring antibiotic administration to the agent appropriate for the organism and type of infection reduces the pressure on organisms to develop antibiotic resistance. In addition, it is now becoming clearer that the health-promoting gut microbiome can be permanently altered by multiple courses of antibiotics.  Antibiotic stewardship reduces unnecessary exposure to antibiotics, and better preserves the normal gut microbiome.  Dialysis patients are often prescribed courses of antibiotics, including wide spectrum agents.  Antibiotic stewardship programs in dialysis facilities have the potential to substantially reduce unnecessary exposure of patients to these antibiotics.

NTDS EDUCATIONAL SERIES

This webinar is the second offering in the NTDS educational series for dialysis caregivers.  The first webinar, attended by over 500 nephrologists and other professionals, was entitled “Targeting Zero Infections: Where Do We Begin?”.  This case-based conference stressed several key educational points, including the virulence of hepatitis C, the role of the nephrologist as a leader, and direction to the online resource library.

NTDS’ educational series will continue during ASN’s Kidney Week 2017:

  • November 1, 2017:   Early Program seminar: “The Dialysis Infection Crisis in the United States: A Call to Action” (Register here)
  • November 2, 2017:   Focus Group session
  • November 3, 2017:   Annual session: “Infection Prevention: Are You Prepared for the Next Ebola?”

For the coming year, NTDS will continue to expand its education and physician engagement activities, present a series of articles in Clinical Journal of the American Society of Nephrology, complete and share a curriculum for trainees and medical directors to stop preventable infections, complete and share a guideline for anticipating and preparing for emerging threats, and encourage collaboration between dialysis professionals and state/federal HAI programs.  In addition, NTDS will work with dialysis facilities to develop and refine programs to transform the dialysis culture to a culture of safety and individual accountability.  By engaging nephrologists, dialysis facility owners, and other stakeholders in these many transforming activities, NTDS believes we can get to our target of zero preventable infections.

WEBINAR Speakers

kliger.jpg

ALAN S. KLIGER, MD


NTDS CHAIR

Yale New Haven Health System

ikizler.jpg

T. ALP IKIZLER, MD, FASN


Current & Emerging Threats Co-Chair

Professor of Medicine
Director of Clinical Research in Nephrology

Director, Master of Science in Clinical Investigation Program

Vanderbilt University School of Medicine

dagata.jpg

ERIKA D’AGATA, MD, MPH


Current & Emerging Threats Member
Associate Professor of Medicine

Brown University

Area(s) of Interest:
Date:
Thursday, September 7, 2017